AzTrials
AzTrials

Dental Pulp ExposureNCT02487329

The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping

A study testing Calcium Hydroxide, Er,Cr:YSGG laser + calcium hydroxide and TheraCal LC in people with Dental Pulp Exposure, run by Near East University, Turkey.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this randomized clinical study was to evaluate the efficiency of Er,Cr:YSGG laser irradiation combined with a resin based tricalcium silicate material and calcium hydroxide (CH) in direct pulp capping for 3 months follow-up period.Sixty permanent vital teeth without symptoms and radiographic changes… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Dental Pulp Exposure
What is being tested?
Calcium Hydroxide, Er,Cr:YSGG laser + calcium hydroxide and TheraCal LC
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
Jan 2015to Jun 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Permanent teeth with deep caries without symptoms
  • Vital teeth
  • No periapical radiographic changes
  • The diameter of the exposed area is between 0,5 mm to 1,5 mm

Who cannot join

  • Spontaneous pain,
  • Tenderness to percussion and palpation,
  • Bleeding lasting over 3 minute after exposure,
  • Periapical radiographic changes such as periradicular or furcal radiolucency, a widened periodontal ligament space and resorption.

About this study

Official title: Efficacy of Er,Cr:YSGG Laser Irradiation Combined With Resin Based Tricalcium Silicate and Calcium Hydroxide on Direct Pulp Capping: a Randomized Clinical Trial

The purpose of this randomized clinical study was to evaluate the efficiency of Er,Cr:YSGG laser irradiation combined with a resin based tricalcium silicate material and calcium hydroxide (CH) in direct pulp capping for 3 months follow-up period.Sixty permanent vital teeth without symptoms and radiographic changes were randomly assigned to 4 groups (n=15): Gr 1: The exposed area was sealed with CH paste, Gr 2: The treated area was sealed with CH paste following Er,Cr:YSGG laser irradiation at an energy level of 0,5 W without water and 45% air, Gr 3: Resin based tricalcium silicate material (TheraCal LC) was applied directly to the exposed pulp, Gr 4: TheraCal LC was applied following irradiation with Er,Cr:YSGG laser.

Read the detailed description

CH is used as gold standard in pulp capping procedures due to its beneficial properties such as induction of mineralization and inhibition of bacterial growth; however tunnel defects and cell inclusions in dentin bridges formed by CH may lead to leakage and bacteria penetration resulting in loss of vitality.

TheraCal LC is a new light-cured, resin-modified, tricalcium silicate based material designed to use for direct and indirect pulp-capping aiming to achieve a bond to composite resins thus reducing micro-leakage.The formulation of TheraCal LC containing tricalcium silicate particles in a hydrophilic monomer provides significant calcium release that stimulates hydroxyapatite and secondary dentin bridge formation The use of laser for direct pulp capping has been suggested for the considerable advantages of lasers including decontamination effect, biostimulation effect, hemostatic and coagulant effect.The erbium, chromium-doped:yttrium, scandium, gallium and garnet (Er,Cr:YSGG) laser which is a relatively new device has been reported to ablate dental hard tissues thanks to its high absorption in water and also strong absorption by the hydroxyl radicals present in the hydroxyapatite structure

Being tested
Calcium Hydroxide, Er,Cr:YSGG laser + calcium hydroxide, TheraCal LC, Er,Cr:YSGG laser + TheraCal LC
Keywords
Direct pulp capping, Er,Cr:YSGG laser, Tricalcium silicate
Medical subject headings
Dental Pulp Exposure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Calcium HydroxideOther

    Also called Dycal, Dentsply, Tulsa, OK, USA

    Exposed area was sealed with a self-hardening calcium hydroxide paste then final restoration was completed using a resin-modified glass ionomer and a nanohybrid composite resin

  • Er,Cr:YSGG laser + calcium hydroxideOther

    Also called Er,Cr:YSGG laser (Waterlase MD, Biolase, Irvine, CA, USA)

    After the exposed area was irradiated with Er,Cr:YSGG laser at an energy level of 0,5 W, a repetition rate of 20 Hz, 140 µs pulse duration with 0% water and 45% air for 10 s, it was sealed with a self-hardening calcium hydroxide paste.Then final restoration was completed using a resin-modified glass ionomer and a nanohybrid composite resin

  • TheraCal LCOther

    Also called TheraCal LC, Bisco, Schaumburg, Illinois, USA

    TheraCal LC was applied directly to the exposed pulp with a needle tip syringe in incremental layers that was not to exceed 1 mm in depth. Then final restoration was completed using a resin-modified glass ionomer and a nanohybrid composite resin

  • Er,Cr:YSGG laser + TheraCal LCOther

    After the exposed area was irradiated with Er,Cr:YSGG laser at an energy level of 0,5 W, a repetition rate of 20 Hz, 140 µs pulse duration with 0% water and 45% air for 10 s, TheraCal LC was used to seal the treated area. Then final restoration was completed using a resin-modified glass ionomer and a nanohybrid composite resin

Study groups in NCT02487329
Study groupRoleWhat they receive
Calcium hydroxideActive comparatorDirect pulp capping with a self-hardening calcium hydroxide paste
Receives: Other: Calcium Hydroxide
Er,Cr:YSGG laser + calcium hydroxideExperimentalDirect pulp capping using Er,Cr:YSGG laser combined with calcium hydroxide
Receives: Other: Er,Cr:YSGG laser + calcium hydroxide
TheraCal LCExperimentalDirect pulp capping with resin based tricalcium silicate material
Receives: Other: TheraCal LC
Er,Cr:YSGG laser + TheraCal LCExperimentalDirect pulp capping using Er,Cr:YSGG laser combined with resin based tricalcium silicate material
Receives: Other: Er,Cr:YSGG laser + TheraCal LC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pulp vitality

    Pulp vitality is assessed with electric pulp tester as vital or non-vital

    Measured: 3 months

  2. Assessment of pain with questionnaire

    Pain assessment is carried out using the pain Numerical Rating Scale (NRS) with ratings between 0 to 9. No reactions to thermal stimuli and no tenderness to percussion.

    Measured: 3 months

Secondary outcomes (1)
  1. Radiographic success

    No signs of root resorption (internal or external), no signs of furcation involvement or periapical radiolucency, no signs of loss of lamina dura, no widened periodontal ligament space

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2015 (estimated)
  2. Study startJan 2015
  3. Primary completionJun 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02487329
Sponsor's protocol ID
2015/30-197
Status last verified
Jun 2015
First submitted
22 Jun 2015
Last updated
1 Jul 2015
Results posted
No
Data monitoring committee
No

Publications

  • Olivi G, Genovese MD, Maturo P, Docimo R. Pulp capping: advantages of using laser technology. Eur J Paediatr Dent. 2007 Jun;8(2):89-95.

    PubMed 17571933
  • Yazdanfar I, Gutknecht N, Franzen R. Effects of diode laser on direct pulp capping treatment : a pilot study. Lasers Med Sci. 2015 May;30(4):1237-43. doi: 10.1007/s10103-014-1574-8. Epub 2014 Apr 23.

    PubMed 24756324

Questions about this trial

What is this clinical trial studying?

A study testing Calcium Hydroxide, Er,Cr:YSGG laser + calcium hydroxide and TheraCal LC in people with Dental Pulp Exposure, run by Near East University, Turkey.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pulp vitality (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02487329, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in